Reaktionsgleichung
C[C:2]1[C:7]([OH:8])=[CH:6][C:5]2[CH2:9][CH2:10][C@:11]([CH2:14][CH2:15]/[CH:16]=[C:17](/[CH2:19][CH2:20]/[CH:21]=[C:22](/[CH2:24][CH2:25][CH:26]=[C:27]([CH3:29])[CH3:28])\[CH3:23])\[CH3:18])([CH3:13])[O:12][C:4]=2[C:3]=1C.CC1C2O[C@@](CC/C=C(/CC/C=C(/CCC=C(C)C)\C)\C)(C)CCC=2C=C(O)C=1>>[CH3:28][C:27]([CH3:29])=[CH:26][CH2:25][CH2:24]/[C:22](/[CH3:23])=[CH:21]/[CH2:20][CH2:19]/[C:17](/[CH3:18])=[CH:16]/[CH2:15][CH2:14][C:11]1([CH3:13])[O:12][C:4]2[CH:3]=[CH:2][C:7]([OH:8])=[CH:6][C:5]=2[CH2:9][CH2:10]1Komponenten
3
Versuchsvorschrift
Both γ-tocotrienol, referred to herein as Compound 1, and δ-tocotrienol, referred to herein as Compound 2, were isolated from a tocotrienol-rich fraction of palm oil using normal phase vacuum liquid chromatography. Compounds 3-29 and 35-44 which are 3,4-dihydro-1,3-oxazines, Compounds 30-31 which are Mannich bases, and Compounds 32-34 which are hydroxymethyl tocotrienol analogs were prepared as semi synthetic derivatives of Compounds 1 and 2.
Quellen und Nachweise
- ORD-Eintrag
- ord-acdb35f1be1944a99c519740ecd14e79
- Quelldatensatz
- uspto-grants-2015_08
- Patentnummer
- US09115145B2
Verknüpfte Notizen
Wird geladen…